advancing care for patients with egfr mutation–positive nsclc: precision medicine strategies
Published 3 years ago • 648 plays • Length 53:55Download video MP4
Download video MP3
Similar videos
-
58:24
time for even more precision in testing and treatment of egfr-mutated nsclc
-
28:28
patient selection, therapeutic sequencing, & treatment selection in egfr mutation-positive nsclc
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
1:05:12
new horizons in egfr-mutated nsclc: broadening the impact of precision testing
-
52:36
making precision decisions in the treatment of nsclc with common and uncommon egfr mutations
-
1:02:40
new milestones and changing standards of care in early egfr-mutated nsclc
-
1:18:11
management of egfr-mutant lung cancer with central nervous system metastases
-
45:57
refining precision decisions in nsclc with common and less common egfr mutations
-
6:08
flaura study: a new standard of care for patients with egfr mutated nsclc
-
41:23
multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings
-
41:59
testing for common and uncommon egfr mutations to guide egfr-targeted therapy in nsclc
-
10:39
gracecast - lcvl - can patients with an egfr mutation-positive advanced nsclc benefit from immunothe
-
1:00:20
it’s precisely the time for more precision in genomic testing and targeted treatment of nsclc
-
43:35
maximizing the impact of egfr-targeted therapy in resectable nsclc
-
8:28
precision medicine for nsclc and the role of apps
-
2:21
treatment of egfr nsclc after progression
-
1:37
dr. konduri on treatment options for patients with egfr-mutant nsclc
-
1:18:32
advanced gi cancers: identifying and targeting uncommon but actionable genomic alterations
-
1:04:49
everything you need to know about molecular testing and targeted therapies in nsclc